BGI Genomics Co., Ltd. (SHE:300676)
China
· Delayed Price · Currency is CNY 45.03
+0.37 (0.83%)
At close: Dec 5, 2025
BGI Genomics Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 17,285 | 16,005 | 19,676 | 21,188 | 35,990 | 50,923 | Upgrade
|
| Market Cap Growth | -11.35% | -18.66% | -7.14% | -41.13% | -29.32% | 85.26% | Upgrade
|
| Enterprise Value | 14,385 | 11,837 | 14,568 | 14,557 | 28,800 | 47,594 | Upgrade
|
| Last Close Price | 45.03 | 41.97 | 47.86 | 50.67 | 85.65 | 125.02 | Upgrade
|
| PE Ratio | - | - | 211.80 | 26.39 | 24.63 | 24.38 | Upgrade
|
| Forward PE | 687.81 | 25.09 | 25.09 | 25.09 | 35.26 | 24.70 | Upgrade
|
| PS Ratio | 4.65 | 4.14 | 4.52 | 3.00 | 5.32 | 6.06 | Upgrade
|
| PB Ratio | 1.84 | 1.73 | 1.97 | 2.07 | 3.81 | 8.45 | Upgrade
|
| P/TBV Ratio | 1.95 | 1.83 | 2.10 | 2.20 | 3.99 | 8.91 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 17.20 | 15.42 | Upgrade
|
| P/OCF Ratio | - | 167.21 | 48.14 | 161.89 | 14.54 | 14.14 | Upgrade
|
| EV/Sales Ratio | 3.87 | 3.06 | 3.35 | 2.06 | 4.26 | 5.67 | Upgrade
|
| EV/EBITDA Ratio | - | - | 30.18 | 11.53 | 14.70 | 16.16 | Upgrade
|
| EV/EBIT Ratio | - | - | 128.98 | 16.08 | 17.14 | 18.01 | Upgrade
|
| EV/FCF Ratio | -22.52 | - | - | - | 13.76 | 14.42 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.05 | 0.04 | 0.02 | 0.09 | 0.22 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.66 | 0.15 | 0.41 | 0.45 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 0.41 | 0.40 | Upgrade
|
| Asset Turnover | 0.29 | 0.30 | 0.31 | 0.49 | 0.53 | 0.98 | Upgrade
|
| Inventory Turnover | 3.79 | 3.93 | 3.34 | 4.42 | 3.02 | 5.00 | Upgrade
|
| Quick Ratio | 2.49 | 2.14 | 2.13 | 2.23 | 2.94 | 1.87 | Upgrade
|
| Current Ratio | 2.81 | 2.42 | 2.41 | 2.47 | 3.26 | 2.21 | Upgrade
|
| Return on Equity (ROE) | -8.42% | -9.46% | 0.93% | 8.23% | 19.11% | 40.32% | Upgrade
|
| Return on Assets (ROA) | -3.57% | -3.52% | 0.50% | 3.95% | 8.25% | 19.32% | Upgrade
|
| Return on Capital (ROIC) | -4.47% | -4.58% | 0.68% | 5.46% | 11.91% | 27.97% | Upgrade
|
| Return on Capital Employed (ROCE) | -7.30% | -7.60% | 1.10% | 8.70% | 15.50% | 35.80% | Upgrade
|
| Earnings Yield | -4.63% | -5.64% | 0.47% | 3.79% | 4.06% | 4.11% | Upgrade
|
| FCF Yield | -3.70% | -2.71% | -4.21% | -5.36% | 5.81% | 6.48% | Upgrade
|
| Dividend Yield | - | - | 0.21% | 1.97% | 0.41% | 0.28% | Upgrade
|
| Payout Ratio | - | - | 448.58% | 20.82% | 12.16% | 2.98% | Upgrade
|
| Buyback Yield / Dilution | -2.32% | -0.01% | -0.48% | 0.32% | -3.11% | 0.20% | Upgrade
|
| Total Shareholder Return | -2.32% | -0.01% | -0.27% | 2.29% | -2.70% | 0.48% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.